We've updated our Privacy Policy to make it clearer how we use your personal data. We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement

Neurodegeneration – Multimedia

Video

Disease Modelling and Drug Discovery in Neurological Disorders

Zameel Cader, Director and Principal Scientist, IMI StemBANCC, University of Oxford, speaking at Stem Cells in Drug Discovery.
Differences in the Neurophysiology of Infants with Down Syndrome May Predict Protective/Risk Markers for Subsequent Alzheimer’s Disease content piece image
Poster

Differences in the Neurophysiology of Infants with Down Syndrome May Predict Protective/Risk Markers for Subsequent Alzheimer’s Disease

Our work set out to understand early individual differences in memory abilities of infants with DS that may be predictive of subsequent cognitive phenotypes of AD.
Metabolomic profile of multiple sclerosis patients by means of 1H-NMR analysis content piece image
Poster

Metabolomic profile of multiple sclerosis patients by means of 1H-NMR analysis

Multiple sclerosis (MS) is a chronic disease characterized by a high level of heterogeneity. Metabolomics is an “-omics” approach with the potential to discover new biomarkers.
A New Dual Luciferase Assay Using NanoLuc® Enables a Second Generation Coincidence Reporter System to Reduce False Hits in HTS Poster content piece image
Poster

A New Dual Luciferase Assay Using NanoLuc® Enables a Second Generation Coincidence Reporter System to Reduce False Hits in HTS Poster

Luciferase-based reporter-gene assays remain a cornerstone of high-throughput screening of compounds because of their high sensitivity and dynamic range. However, a substantial number of non-relevant hits can be generated due to direct interaction of compounds with the luciferase reporter.
Knockdown of p53 by Accell Self-delivering siRNA Causes Inhibition of p53-dependent DNA Damage Response in IMR-32 Neuroblastoma Cell Line and β-amyloid Toxicity in Rat Cortical Neurons  content piece image
Poster

Knockdown of p53 by Accell Self-delivering siRNA Causes Inhibition of p53-dependent DNA Damage Response in IMR-32 Neuroblastoma Cell Line and β-amyloid Toxicity in Rat Cortical Neurons

Here we describe how application of Accell siRNA enabled the development of a high content screening assay in IMR-32 neuroblastoma cells and a whole culture cell viability assay in primary rat cortical neurons.
Alzheimer's Disease Model Cells Derived from Human iPS Cells content piece image
Poster

Alzheimer's Disease Model Cells Derived from Human iPS Cells

Alzheimer's disease model neurons were created from iPS cells to enable functional, cell-based assays for AD.
Video

Biomarkers from Discovery to Clinical Diagnostics Applications of Single-Molecule Array (Simoa) Technology

Andreas Jeromin, Atlantic Biomarkers, speaking at Diagnostics & Biomarkers 2015.
Recent Foodomic Developments to Investigate the Bioactivity of Dietary Ingredients content piece image
Video

Recent Foodomic Developments to Investigate the Bioactivity of Dietary Ingredients

In this work, we will present the fundamentals of Foodomics, discussing the role of this new discipline to solve some current and future challenges in food science and nutrition, and showing several Foodomics applications carried out in our laboratory related to food quality and food bioactivity.
Fighting Blindness with 3D-NET "Drug Discovery & Development of Novel Eye Therapeutics" content piece image
Poster

Fighting Blindness with 3D-NET "Drug Discovery & Development of Novel Eye Therapeutics"

3D-NET, “Drug Discovery & Development of Novel Eye Therapeutics”, is a new European research consortium of industry and academic partners focusing efforts to enhance the discovery and development of drugs targeting ocular pathologies that lead to blindness.
Liposomes and Nanoparticles as Delivery Vehicles for the Treatment of Lung Diseases content piece image
Poster

Liposomes and Nanoparticles as Delivery Vehicles for the Treatment of Lung Diseases

Targeted nanoparticle-based drug delivery to the lungs is an emerging area of interest for both scientists and medical workers because it allows better drug retention in the lungs and can provide prolonged drug release. In our study we investigated the potential of using liposomes and polymeric nanoparticles surface modified with a specific antibody as drug carriers for targeted drug delivery to the lungs.
Advertisement